VanEck, the asset manager behind a range of thematic exchange-traded funds, is betting that two technology sectors will lead innovation by 2026: biotechnology and orbital infrastructure. The firm's analysis highlights these areas as the primary engines of change in the coming years, offering investors a roadmap for where to look for growth.
Why Biotech Leads
Biotech covers everything from gene editing to drug development, and VanEck sees it as a key driver of innovation. The sector's ability to reshape medicine, agriculture, and industrial processes makes it a focal point. The firm's identification of biotech as a top theme reflects the accelerating pace of scientific breakthroughs and the growing capital flowing into the field.
Orbital Infrastructure Takes Shape
Orbital infrastructure encompasses the build-out of satellite networks, space stations, and related systems in low-Earth orbit. VanEck points to this as a transformative area, driven by both commercial ventures and government programs. As space becomes more accessible, the infrastructure to support it is turning into a critical part of the global economy — from internet connectivity to Earth observation.
ETFs as a Targeted Tool
For investors wanting exposure without betting on a single company, VanEck notes that ETFs offer a practical solution. Thematic ETFs concentrate capital on specific sectors, and for early-stage industries like biotech and orbital infrastructure, that structure can reduce risk while staying focused. VanEck's own lineup includes funds that track such themes, though the firm says ETFs in general provide the targeted access these sectors demand.
VanEck's identification of biotech and orbital infrastructure as key tech themes gives a clear signal on where the firm expects innovation to concentrate. Both fields are still evolving rapidly, and whether one pulls ahead or they advance together remains an open question. For now, VanEck's analysis puts them at the center of the innovation map through 2026.
